# A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

> **NCT05105672** · PHASE2 · UNKNOWN · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Uterine Cervical Neoplasms
- Sintilimab

## Interventions

- **DRUG:** Sintilimab
- **DRUG:** Cisplatin
- **RADIATION:** External Beam Radiotherapy (EBRT)
- **RADIATION:** brachytherapy

## Key facts

- **NCT ID:** NCT05105672
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-08
- **Primary completion:** 2023-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105672, "A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05105672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*